Skip To Main Content
Nisebita Sahu on Muck Rack

Nisebita Sahu

As seen in: British Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nisebita

Contact Nisebita, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Nisebita Sahu, Darlene Cruz, Min Gao, Wendy Sandoval, Peter M. Haverty, Jinfeng Liu, Jean-Philippe Stephan, Benjamin Haley, Marie Classon, Georgia Hatzivassiliou, Jeff Settleman
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?
|
By Nisebita Sahu, Darlene Cruz, Min Gao, Jinfeng Liu, Jean-Philippe Stephan, Benjamin Haley, Jeff Settleman, Wendy Sandoval, Peter M. Haverty, Marie Classon, Georgia Hatzivassiliou
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?

Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs

|
By Nisebita Sahu, Darlene Cruz, Jean-Philippe Stephan, Mark Merchant
| British Journal of Cancer Verified
PC9 cells were from Kyushu University, Japan. EVSA-T and MKN-45 cells were from DSMZ. All other cell lines were from American Type Culture Collection. All cell lines were banked at the Genentech cell line core facility that routinely performs single nucleotide polymorphism (SNP) and short tandem repeats (STR) analysis to confirm cell line identity and detect possible mycoplasma contamination.
Open in Who Shared Issue with article?
See all 3 articles